Newly Diagnosed Diabetes in Patients with COVID-19: Different Types and Short-Term Outcomes

Faculty Medicine Year: 2031
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Tropical Medicine and Infectious Disease MDPI Volume:
Keywords : Newly Diagnosed Diabetes , Patients with COVID-19: Different    
Abstract:
A great global concern is currently focused on the coronavirus disease 2019 (COVID-19)pandemic and its associated morbidities. Aim of the study: The goal of this study was to determine the frequency of newly diagnosed diabetes mellitus (DM) and its different types among COVID-19 patients, Patients and method: 570 patients with confirmed COVID-19 were studied. All participants were classified as non-diabetic or newly discovered diabetic. According to hemoglobin A1c (HbA1c) and fasting insulin, newly discovered diabetic patients were further clnewly diagnosed diabetic Results: patients. DM was diagnosed in 77 patients (13.5%); 12 (2.1%) with pre-existing DM, 7 (1.2%) with new-onset type 1 DM, and 58 (10.2%) with new-onset type 2 DM. Significantly higher rates of severe infection and mortality (p < 0.001 and p = 0.046) were evident among diabetic patientsassified into pre-existing DM, new-onset type 1 DM, and new-onset type 2 DM. Conclusion :COVID-19 was associated with a new-onset of DM in 11.4% of all participants and expression of pre-existing DM in 2.1% of all participants, both being associated with severe infection. COVID-19 patients with newly diagnosed diabetes had high risk of mortality
   
     
 
       

Author Related Publications

  • Khalid Ahmed Mohammed Al-Banna, "Urinary Neutrophil Gelatinase-Associated Lipocalin as an early marker for diagnosis of diabetic nephropathy in T2DM patients and its correlation to albumin creatinine ratio", Association of Cell Biology Romania, 2021 More
  • Khalid Ahmed Mohammed Al-Banna, "Proinsulin/insulin ratio as a predictor of insulin resistance and B-cell dysfunction in obese Egyptians ((insulin resistance&B-cell dysfunction in obese Egyptians", Clinical Research and Reviews, 2019 More
  • Khalid Ahmed Mohammed Al-Banna, "Serum Pentraxin 3 level as a recent biomarker of diabetic retinopathy in Egyptian patients with diabetes", Elsevier Ltd, 2019 More
  • Khalid Ahmed Mohammed Al-Banna, "Effect of Glucagon Like Peptide 1|(GLP1) Analogues on Obese Egyptians with &without Diabetes", Medical Journal of Cairo University, 2019 More
  • Khalid Ahmed Mohammed Al-Banna, "Urinary Adiponectin as a Diagnostic and Prognostic Marker in Diabetic Nephropathy", Al Azhar Assiut Medical Journal, 2015 More

Department Related Publications

  • Ayman Abdalrahman Mohamed Nasrllah, "Thyroid Dysfunction and Inflammatory Biomarkers in COPD:Relation to Severity and Exacerbation", Cairo,Egypt, 2013 More
  • Emad Fawzy Hamed Mahmoud, "ANNEXIN A2 VERSUS AFP AS AN EFFICIENT DIAGNOSTIC SERUM MARKER FOR HEPATOCELLULAR CARCINOMA", المجله المصريه الافريقيه للامراض المتوطنه, 2013 More
  • Ayman Abdalrahman Mohamed Nasrllah, "Fraility:Identification and Markers", London, 2013 More
  • Emad Fawzy Hamed Mahmoud, "Hepatitis C Virus Reactivation in Patients with Heamatological Malignancies, Single Egyptian Center Study", life science journal, 2013 More
  • Emad Fawzy Hamed Mahmoud, "PARAOXONASE 1 Gene Polymorphism Relationship with Type 2 Diabetes Mellitus", life science journal, 2012 More
Tweet